REN and COVID-19: As the RAS is activated in VILI [16, 25] and in ARDS [22, 23], this may have influenced renin and aldosterone levels in patients with COVID-19 in these studies and, apart from methodological differences [35], may explain the differing results that aldosterone levels were lower [33] or higher [34] in patients with severe COVID-19.